Reviva Pharmaceuticals Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for RVPH, updated each market day.
RVPH AI Sentiment
AI predicts Reviva Pharmaceuticals Holdings, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Reviva Pharmaceuticals Holdings, Inc. Common Stock
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
Sector
Exchange
Market Cap
$10,824,768
Cap Tier
Employees
14
Headquarters
CUPERTINO, CA
Listed Since
Dec. 15, 2020
Website
RVPH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RVPH Volatility
Reviva Pharmaceuticals Holdings, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
